CD44 and neoplasm: Another study used polymer micelles coupled with miR-205 and gemcitabine to target markers such as OCT3/4, CD44, and Tubulin 3, showing a substantial reduction in tumor volume, implying that pancreatic cancer cells’ sensitivity to gemcitabine was restored [255].